ドーパミン再吸収とヒトのドーパミントランスポーターにおける抑制メカニズム
Yue Li1,2,3, Xianping Wang1,3, Yufei Meng1,3
1Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Nature
|August 7, 2024
まとめ
研究者らはヒトのドーパミントランスポーターを明らかにした
科学分野:
- 神経科学
- 構造生物学
- 薬理学について
背景:
- ドーパミントランスポーター (DAT) はドーパミナー神経伝達を調節し,精神運動刺激剤の乱用に関与しています.
- ヒトのDAT構造,基板結合,および薬物相互作用に関する以前の理解は限られていた.
研究 の 目的:
- サブストラットと薬物結合を含むヒトのDAT機能の構造的基礎を解明する.
- トランスポーター調節と治療開発に関連する形状の変化と薬物結合の姿勢を理解する.
主な方法:
- アポ,ドーパミン結合,薬物結合状態のヒトDATの結晶構造 (メチルフェニデート,GBR12909,ベンツトロピン) が報告されています.
- 異なる結合モードと構成状態 (遮蔽,外向き,内向き) を分析した.
主要な成果:
- 閉塞したDAT内のドーパミン結合の詳細な構造.
- 構造は,外向き (コカイン) と内向き (ベンツトロピン) の状態で薬物結合を明らかにします.
- GBR12909とベンツトロピンは内向きの形状を安定させ,そのメカニズムに関する新しい洞察を提供し,コカインと対照的です.
結論:
- 人間のDAT輸送メカニズムを理解するための構造的枠組みを提供します.
- ADHD薬とDAT阻害剤の結合に関する洞察を提示しています
- DAT関連疾患と依存症の新たな治療法の開発のための基礎を築きます.
さらに関連する動画
関連する概念動画
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
The Significance of Membrane Transport
24.6K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
24.6K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
290
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
290


